The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling pathway
Preprint in Research Square (November 2023)
The most recent citing publications are shown below. View all 66 publications that cite this research output on Dimensions.
Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment
Article in Heliyon (November 2023)
An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
Article in Biochemical and Biophysical Research Communications (November 2023)